A common story with the newer weight-loss drugs goes like this: the weight comes off fast, and then a couple of months later hair starts turning up on the pillow and clogging the shower drain. That pattern has a name, telogen effluvium, and it's temporary. It happens on Ozempic and Wegovy as well as Mounjaro and Zepbound, and it almost always comes back. How quickly depends mostly on when your body stops treating the weight loss as a stress, so I'd start the clock from that point rather than from the first handful of hair in the drain.

No study has yet followed GLP-1 users' hair month by month through recovery, so the timeline here is built from what's well established about telogen effluvium after weight loss, applied to the way these drugs work.

How common it is, and what's actually causing it

In April 2026, a team led by the Canadian dermatologist Aditya Gupta, with the hair specialist Paradi Mirmirani among the authors, published a systematic review of 24 studies on GLP-1 drugs and hair loss in Science Progress. The clearest numbers come from the drug trials. Wegovy's trials, which tested semaglutide at 2.4 mg a week, found hair loss in about 3 people in every 100 on the drug, compared with 1 in 100 on placebo. Across the tirzepatide weight-loss trials, it was 5.4% against 0.9%.

Two details in those trials point at the cause. Hair loss was more common among the people who lost the most weight: in the Wegovy trials it showed up in 5.3% of those who dropped more than a fifth of their body weight, against 2.5% of those who lost less. And in the Zepbound trials, 7.1% of women reported hair loss, against 0.5% of men.

In 2025, a research group writing in the Journal of the American Academy of Dermatology went through the health records of roughly 360,000 people with obesity in the TriNetX research network. Those taking tirzepatide were about two and a half times as likely to be diagnosed with telogen effluvium as people on other weight-loss medications, while their risk wasn't significantly different from that of bariatric surgery patients. That second comparison matters, because surgery can't act on follicles at all; its shedding comes from losing weight fast on too little food.

The review's authors reached the same conclusion. They found no human evidence that these drugs damage follicles directly, and pointed instead to the speed of weight loss and the eating that comes with it. A Korean study of 140 people with weight-loss shedding gives a sense of the threshold: on average, their hair started falling after they'd lost about 15% of their body weight at a rate of roughly 3.5 kilograms a month. That's well within what the newer GLP-1 drugs routinely produce.

When the recovery clock actually starts

Picture someone who starts Zepbound in January and moves up a dose in March. The hair affected by those changes doesn't fall in January or March. It starts coming out around April or May, because the stress shifts a large batch of follicles into their resting phase together, and each of those hairs stays put for a couple of months before it lets go. Gupta's review puts the usual onset at about two to three months after starting or stepping up the dose.

The same lag applies on the way back. If that person's weight loss levels off in September and they're eating properly again, September is the month I'd count from, even though they first noticed the shedding back in the spring. For most people that's when weight loss slows to a steadier pace and eating has caught up, with enough protein and calories most days. If you're still losing several kilos a month on very little food, the clock hasn't really started yet, and new rounds of shedding can keep overlapping with the first.

Counting from there, Gupta's team found improvement usually arrives within three to six months. Past six months, dermatologists call it chronic telogen effluvium, which in practice often means the trigger never fully went away.

From when the trigger eases	What you're likely to see
3 months	Shedding slowing; short new hairs at hairline and part
6 months	Shedding near normal; a visible fringe of regrowth
12 months	Fullness mostly back; long hair still filling in at the ends
Past 12 months, still thin	Worth a dermatologist's look

At 3 months

Somewhere around this point the brush starts coming away cleaner, though not all at once, and for a few weeks it's common to wonder whether things are really improving or you're just hoping. Around the same time, short new hairs start to show along the hairline, at the temples, and on either side of the part. They stick up, they won't lie flat, and they're often finer than the rest. Those are the replacements for the hairs that fell, and they're the best sign that recovery is underway.

Scalp hair grows roughly a centimeter a month, so at this point the new growth is only a few centimeters long. Overall volume won't look much different yet.

At 6 months

By six months of steadier weight and better eating, I'd expect shedding to be back near your normal level, with the new hairs long enough to form a visible fringe and, on shorter styles, the thinning often no longer noticeable.

Take someone who's still shedding heavily at that point. Usually one of two things is going on. Either they're still eating so little that their body hasn't stopped treating it as a crisis, or the shedding has uncovered pattern hair loss that was already developing. Where the thinning sits tells you which, because pattern loss collects in particular places, like the part or the crown, while shedding spreads evenly across the head. Gupta's review describes that unmasking, and it matters because pattern loss won't settle on its own the way shedding does.

At 12 months

For most people with telogen effluvium alone, a year after the trigger eases is when their hair feels like theirs again. Length is what decides how complete it looks. Someone with a short cut has essentially full coverage back. Long hair is the exception. New hairs a year in are roughly the length of a hand, so a shoulder-length style looks full on top well before the ends of a ponytail catch up. A year on, clear thinning, or more scalp showing in one area than another, is the point where I'd want a dermatologist involved. The review itself recommends specialist referral when shedding persists beyond six to nine months.

If it's more than shedding

Of the four tests Gupta's team suggested for shedding that's heavy or won't let up, ferritin is the one I'd most want to see, since iron is easy to run short on when you're eating much less. The others are a blood count, thyroid function, and vitamin D, and your prescriber can order them together.

Their advice on pattern thinning was more direct. Thinning that collects in one area, they wrote, should be treated as androgenetic alopecia, with standard options like topical minoxidil. That's the over-the-counter treatment FDA-approved for mild-to-moderate pattern loss, at 2% for women and 5% for men, and it needs a few months before you can judge it. Neither shedding nor pattern loss makes the scalp itch or scale, or leaves smooth bald patches, so either of those needs a separate diagnosis.

On the drug itself, the review mentions slower dose escalation, or a short pause in severe cases, as options. Those are your prescriber's to weigh against everything else the medication is doing for you, so I wouldn't change the dose on your own because of your hair.

What helps the hair come back

Protein is where I'd start. On these drugs it's easy to go from three meals to one small one without registering the change, and hair is made almost entirely of protein. Gupta's review also mentions keeping an eye on iron, zinc, and a few vitamins, though I'd let a blood test decide whether you need to supplement any of them. New hairs coming in are fine and break easily, so I'd go easy on tight ponytails and heavy heat for a while.

Where MDhair fits

The MDhair GLP-1 Hair Support Kit, available on Amazon, brings together three products made for hair that's recovering from the nutritional shift of rapid weight loss.

Restore Supplements give your hair a nutrient backup while your eating settles. They have more than 20 vitamins and plant-based complexes chosen for nutrient replenishment and hair strength, including biotin, iron, zinc and B vitamins. Your follicles keep getting what they need on days when your appetite doesn't cooperate. They support a balanced diet rather than replace it.

Marine Collagen helps fill the protein gap that's so common on a GLP-1. Hair is made almost entirely of protein, and smaller meals make it harder to get enough. A daily scoop of collagen powder is an easy way to add amino acids without having to eat more.

Restore Serum is a leave-on scalp serum from our bond-building line, made for the fragile new strands that grow back during recovery and tend to break easily. It has copper peptides and topical saw palmetto, which makes it one of our DHT-blocker formulas. That helps if the shedding has uncovered early pattern thinning.

Together they cover hair from three sides: nutrients from the inside, protein to build with, and support on the scalp itself.

My team and I ran a six-month clinical trial of MDhair's personalized regimen, published in the Journal of Drugs in Dermatology in 2025. We compared our regimen with the leading hair loss supplement brand. At 90 days, hair growth had improved about 2.8 times as much and hair quality about 3.0 times as much. The participants weren't GLP-1 users, so read it as evidence for a well-built routine, not as a forecast for your own hair.

You're already on a prescription drug, so tell your prescriber before you add a supplement.

If you're on a GLP-1 and want to know whether this is shedding alone or something more, our free AI hair and scalp assessment starts with a short quiz about your hair history and a scalp photo, then matches a regimen to what it finds. Every regimen includes unlimited chat access to our dermatologist team.

Dr. Yoram Harth is a board-certified dermatologist and Co-Founder and Chief Medical Officer of MDalgorithms Inc., the company behind MDhair and MDacne. A magna cum laude graduate of Tel Aviv University's Sackler School of Medicine, he trained in dermatology at Rambam Medical Center and completed a research fellowship at Columbia-Presbyterian Medical Center in New York. His work spans phototherapy, photodynamic therapy, and AI-personalized skin and hair care.

Sources

Studies were located through PubMed and the publishing journals' own sites.

1. Gupta AK, Teasell EM, Economopoulos V, Mirmirani P. GLP-1 therapies and hair loss: a systematic review of current evidence and implications for counseling. Sci Prog. 2026;109(2). doi:10.1177/00368504261444578
2. Neubauer Z, Ong MM, Singal A, et al. Increased risk of telogen effluvium with tirzepatide compared to other weight loss medications: a retrospective cohort TriNetX database study. J Am Acad Dermatol. 2025;93:1612-1614. doi:10.1016/j.jaad.2025.08.033
3. Kang DH, Kwon SH, Sim WY, Lew BL. Telogen effluvium associated with weight loss: a single center retrospective study. Ann Dermatol. 2024;36(6):384-388. doi:10.5021/ad.24.043
4. Bhardwaj V, Rodgers N, Harth O, Harth Y. Artificial intelligence-based personalization of treatment regimen for hair loss: a 6-month clinical trial. J Drugs Dermatol. 2025;24(3):233-238. doi:10.36849/JDD.8611

Find the most effective hair growth products for you by taking the free hair assessment.